NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $41.47
  • Forecasted Upside: -16.66 %
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$49.76
▼ -0.3 (-0.60%)
1 month | 3 months | 12 months
Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$41.47
▼ -16.66% Downside Potential
This price target is based on 14 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $41.47, with a high forecast of $60.00 and a low forecast of $20.00. The average price target represents a -16.66% upside from the last price of $49.76.
Buy
The current consensus among 14 investment analysts is to buy stock in Tenet Healthcare. This rating has held steady since July 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/5/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/3/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/21/2021UBS GroupBoost Price TargetPositive ➝ Buy$37.00 ➝ $60.00High
i
1/14/2021Raymond JamesBoost Price TargetOutperform$55.00 ➝ $60.00High
i
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$27.00 ➝ $60.00Low
i
1/5/2021Bank of AmericaUpgradeNeutral ➝ Buy$45.00 ➝ $50.00N/A
i
12/18/2020MizuhoBoost Price TargetBuy$32.00 ➝ $48.00Medium
i
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyMedium
i
12/11/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$33.00 ➝ $50.00Medium
i
12/11/2020Smith Barney CitigroupBoost Price Target$33.00 ➝ $50.00High
i
12/11/2020Credit Suisse GroupBoost Price TargetOutperform$39.00 ➝ $48.00Medium
i
12/11/2020BarclaysBoost Price TargetEqual Weight$28.00 ➝ $46.00High
i
11/11/2020Piper SandlerBoost Price TargetNeutral$31.00 ➝ $36.00High
i
11/9/2020MizuhoBoost Price TargetBuy$30.00 ➝ $32.00High
i
10/22/2020Raymond JamesBoost Price TargetOutperform$40.00 ➝ $43.00High
i
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$28.00 ➝ $20.00High
i
9/4/2020Royal Bank of CanadaBoost Price Target$30.00 ➝ $35.00Low
i
8/14/2020TruistBoost Price Target$21.00 ➝ $30.00Medium
i
8/10/2020UBS GroupBoost Price TargetBuy$30.00 ➝ $35.00Low
i
8/5/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$25.00 ➝ $28.00High
i
8/4/2020Credit Suisse GroupReiterated RatingBuyHigh
i
6/11/2020UBS GroupLower Price TargetBuy$32.00 ➝ $30.00High
i
5/29/2020MizuhoLower Price TargetBuy$32.00 ➝ $30.00High
i
5/21/2020SunTrust BanksBoost Price TargetHold$22.00 ➝ $25.00Medium
i
5/20/2020CitigroupLower Price TargetBuy$35.00 ➝ $27.00High
i
5/14/2020UBS GroupLower Price TargetBuy$49.00 ➝ $32.00High
i
5/11/2020BarclaysBoost Price TargetEqual Weight$19.00 ➝ $22.00Low
i
5/6/2020Credit Suisse GroupReiterated RatingBuy$33.00Low
i
5/6/2020Wells Fargo & CompanyLower Price TargetEqual Weight$40.00 ➝ $32.00Low
i
5/6/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$31.00 ➝ $25.00High
i
4/13/2020SunTrust BanksBoost Price TargetHold$18.00 ➝ $22.00Low
i
4/13/2020Royal Bank of CanadaReiterated RatingBuy$26.00Medium
i
4/3/2020SunTrust BanksLower Price TargetHold$42.00 ➝ $18.00High
i
3/25/2020BarclaysReiterated RatingHold$19.00High
i
3/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$32.00 ➝ $39.00High
i
2/26/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$31.00 ➝ $32.00High
i
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$20.00Low
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetUnderweight$23.00 ➝ $31.00Medium
i
12/18/2019SunTrust BanksBoost Price TargetHold$31.00 ➝ $42.00Medium
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/9/2019UBS GroupUpgradeNeutral ➝ Buy$24.00 ➝ $53.00High
i
11/7/2019MizuhoReiterated RatingBuyLow
i
11/6/2019MizuhoBoost Price Target$30.00 ➝ $33.00Low
i
11/6/2019SunTrust BanksBoost Price TargetHold$24.00 ➝ $31.00High
i
Rating by David S Macdonald at SunTrust Banks, Inc.
11/6/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$25.00 ➝ $36.00High
i
8/14/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$28.00 ➝ $28.00High
i
8/11/2019Royal Bank of CanadaReiterated RatingHold$26.00Medium
i
8/7/2019SunTrust BanksSet Price TargetHold$24.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
5/1/2019SunTrust BanksLower Price TargetHold$27.00High
i
4/17/2019BarclaysSet Price TargetHold$24.00Medium
i
Rating by Steven Valiquette at Barclays PLC
2/27/2019Raymond JamesBoost Price Target$37.00 ➝ $47.00Medium
i
2/27/2019CitigroupBoost Price TargetBuy ➝ Buy$35.00 ➝ $37.00High
i
2/26/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$21.00 ➝ $30.00High
i
1/28/2019MizuhoReiterated RatingBuy$28.00Low
i
Rating by Ann Hynes at Mizuho
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$23.00Medium
i
1/6/2019BarclaysReiterated RatingHold$20.00High
i
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$20.00Low
i
12/17/2018Robert W. BairdDowngradeOutperform ➝ NeutralHigh
i
12/3/2018Raymond JamesReiterated RatingBuy$37.00High
i
11/15/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$26.00Low
i
11/7/2018Robert W. BairdReiterated RatingBuy$35.00High
i
11/7/2018BarclaysReiterated RatingHold$27.00High
i
8/14/2018BarclaysInitiated CoverageEqual Weight$35.00Low
i
8/10/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$22.00 ➝ $28.00Low
i
8/8/2018Piper Jaffray CompaniesReiterated RatingHold$34.00Medium
i
8/8/2018SunTrust BanksReiterated RatingHold$35.00Medium
i
8/7/2018MizuhoSet Price TargetBuy$36.00Medium
i
Rating by Ann Hynes at Mizuho
7/23/2018CitigroupBoost Price TargetBuy ➝ Buy$37.00 ➝ $44.00High
i
6/29/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$28.00 ➝ $38.00Medium
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/9/2018MizuhoReiterated RatingBuy$35.00Medium
i
Rating by Ann Hynes at Mizuho
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$27.00 ➝ $37.00Low
i
5/4/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$27.00 ➝ $33.00Low
i
5/2/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$16.00 ➝ $24.00High
i
5/2/2018SVB LeerinkBoost Price TargetOutperform$30.00 ➝ $40.00High
i
4/17/2018SunTrust BanksReiterated RatingHold$27.00Low
i
3/22/2018MizuhoReiterated RatingBuy$29.00High
i
Rating by Sheryl Skolnick at Mizuho
3/5/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$15.00 ➝ $18.00Low
i
3/1/2018Piper Jaffray CompaniesReiterated RatingHold$21.00High
i
3/1/2018SunTrust BanksReiterated RatingHoldHigh
i
Rating by David S Macdonald at SunTrust Banks, Inc.
3/1/2018CitigroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $27.00Low
i
2/28/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$15.00 ➝ $16.00Medium
i
2/28/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $22.00High
i
2/28/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$30.00High
i
2/27/2018Jefferies Financial GroupSet Price TargetBuy$23.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
1/30/2018Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$20.00High
i
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$15.00High
i
12/20/2017SVB LeerinkReiterated RatingBuy$27.00Low
i
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$14.00Medium
i
12/19/2017MizuhoBoost Price TargetNeutral$13.00 ➝ $15.00High
i
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$15.00Medium
i
12/12/2017CitigroupUpgradeNeutral ➝ BuyHigh
i
11/21/2017William BlairReiterated RatingMarket PerformN/A
i
Rating by M. Larew at William Blair
11/13/2017Royal Bank of CanadaLower Price TargetSector Perform$19.00 ➝ $17.00N/A
i
11/10/2017MizuhoReiterated RatingNeutral ➝ HoldN/A
i
11/9/2017Morgan StanleyLower Price TargetEqual Weight$15.00 ➝ $14.00N/A
i
11/8/2017SVB LeerinkReiterated RatingOutperform$30.00 ➝ $25.00N/A
i
Rating by A. Gupte at SVB Leerink LLC
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$15.00N/A
i
10/30/2017Jefferies Financial GroupSet Price TargetBuy$24.00 ➝ $20.00N/A
i
10/15/2017SunTrust BanksSet Price TargetHold$15.00N/A
i
Rating by David S Macdonald at SunTrust Banks, Inc.
9/28/2017Robert W. BairdReiterated RatingBuy$23.00High
i
9/25/2017Royal Bank of CanadaReiterated RatingHold$19.00High
i
9/21/2017Jefferies Financial GroupReiterated RatingBuy$24.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
9/14/2017MizuhoReiterated RatingNeutral$14.00Medium
i
Rating by Sheryl Skolnick at Mizuho
9/14/2017CitigroupReiterated RatingHold$16.00Medium
i
9/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$24.00Low
i
8/24/2017Robert W. BairdReiterated RatingBuy$23.00Low
i
8/24/2017Royal Bank of CanadaReiterated RatingHold$25.00Low
i
8/20/2017MizuhoReiterated RatingNeutral$14.00High
i
Rating by Sheryl Skolnick at Mizuho
8/20/2017SVB LeerinkReiterated RatingOutperform$23.00 ➝ $30.00High
i
Rating by A. Gupte at SVB Leerink LLC
8/10/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$28.00 ➝ $24.00Low
i
8/10/2017CitigroupReiterated RatingNeutral$20.00 ➝ $16.00Medium
i
8/10/2017Robert W. BairdReiterated RatingOutperform$23.00Medium
i
8/9/2017Credit Suisse GroupLower Price TargetNeutral$20.00 ➝ $17.00Low
i
8/8/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$26.00 ➝ $24.00High
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
7/18/2017Royal Bank of CanadaReiterated RatingHold$25.00Medium
i
6/6/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$27.00Medium
i
Rating by A. Gupte at SVB Leerink LLC
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$19.00High
i
6/6/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$22.00Low
i
5/15/2017Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $20.00Medium
i
5/5/2017Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $20.00Low
i
4/29/2017Jefferies Financial GroupReiterated RatingBuy$28.00 ➝ $26.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
4/23/2017MizuhoReiterated RatingNeutral$18.00Low
i
Rating by Sheryl Skolnick at Mizuho
4/13/2017Jefferies Financial GroupReiterated RatingBuy$28.00Low
i
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$28.00High
i
3/27/2017MizuhoLower Price TargetNeutral$22.50 ➝ $18.00High
i
Rating by Sheryl Skolnick at Mizuho
3/6/2017CitigroupLower Price TargetNeutral$22.00 ➝ $20.00N/A
i
3/3/2017Royal Bank of CanadaReiterated RatingHold$25.00N/A
i
2/24/2017MizuhoUpgradeUnderperform ➝ Neutral$13.00 ➝ $22.80N/A
i
Rating by Sheryl Skolnick at Mizuho
2/6/2017Jefferies Financial GroupLower Price TargetBuy$36.00 ➝ $28.00N/A
i
1/24/2017SVB LeerinkReiterated RatingMarket Perform$22.00N/A
i
Rating by ana gupte at SVB Leerink LLC
1/11/2017UBS GroupReiterated RatingBuy$26.00 ➝ $24.00N/A
i
1/3/2017Piper Jaffray CompaniesInitiated CoverageNeutral$16.00N/A
i
11/22/2016MizuhoDowngradeNeutral ➝ Underperform$13.00N/A
i
Rating by Sheryl Skolnick at Mizuho
11/10/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
i
11/10/2016UBS GroupDowngradeOutperform ➝ Market PerformN/A
i
Rating by A.J. Rice at UBS Group AG
11/9/2016Bank of AmericaDowngradeBuy ➝ Neutral$32.00 ➝ $25.00N/A
i
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/A
i
10/5/2016MizuhoLower Price TargetNeutral$28.00 ➝ $22.00N/A
i
Rating by Sheryl Skolnick at Mizuho
9/4/2016SVB LeerinkReiterated RatingMarket Perform$30.00 ➝ $28.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
8/22/2016UBS GroupReiterated RatingBuyN/A
i
Rating by A.J. Rice at UBS Group AG
8/19/2016BarclaysReiterated RatingBuy$39.00N/A
i
Rating by Joshua Raskin at Barclays PLC
8/4/2016CitigroupLower Price TargetNeutral$36.00 ➝ $31.00N/A
i
8/2/2016Morgan StanleyReiterated RatingHold$38.00N/A
i
Rating by Andrew Schenker at Morgan Stanley
8/2/2016MizuhoReiterated RatingNeutral$33.00 ➝ $28.00N/A
i
Rating by Sheryl Skolnick at Mizuho
7/11/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
6/28/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/13/2016LADENBURG THALM/SH SHUpgradeNot Rated ➝ UnderperformN/A
i
5/24/2016UBS GroupReiterated RatingBuy$48.00N/A
i
Rating by A.J. Rice at UBS Group AG
5/16/2016Sterne Agee CRTReiterated RatingBuyN/A
i
Rating by B. Wright at Sterne Agee CRT
5/16/2016Robert W. BairdReiterated RatingBuyN/A
i
Rating by Whit Mayo at Robert W. Baird
5/5/2016JPMorgan Chase & Co.Reiterated RatingHold$36.00N/A
i
5/4/2016CitigroupBoost Price TargetNeutral$27.00 ➝ $36.00N/A
i
5/4/2016MizuhoDowngradeBuy ➝ Neutral$33.00N/A
i
Rating by Sheryl Skolnick at Mizuho
5/3/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Kevin Fischbeck at Bank of America Co.
5/3/2016Morgan StanleyReiterated RatingHoldN/A
i
Rating by Andrew Schenker at Morgan Stanley
5/3/2016Credit Suisse GroupReiterated RatingHold$31.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
5/2/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/13/2016140166UpgradeNeutral ➝ Positive$38.00N/A
i
3/24/2016Credit Suisse GroupBoost Price TargetNeutral$30.00 ➝ $31.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
3/16/2016MizuhoBoost Price TargetBuy$30.00 ➝ $33.00N/A
i
Rating by Sheryl Skolnick at Mizuho
3/7/2016Royal Bank of CanadaReiterated RatingSector Perform$37.00 ➝ $30.00N/A
i
3/2/2016SVB LeerinkReiterated RatingMarket Perform$36.00 ➝ $30.00N/A
i
2/26/2016140166Lower Price Target$30.00 ➝ $23.00N/A
i
2/26/2016BMO Capital MarketsLower Price TargetOutperform$55.00 ➝ $38.00N/A
i
Rating by Jennifer Lynch at BMO Capital Markets
2/25/2016UBS GroupReiterated RatingBuy$51.00 ➝ $48.00N/A
i
Rating by A.J. Rice at UBS Group AG
2/24/2016SunTrust BanksLower Price TargetNeutral$34.00 ➝ $28.00N/A
i
2/24/2016BarclaysReiterated RatingBuy$42.00 ➝ $34.00N/A
i
Rating by Joshua Raskin at Barclays PLC
2/23/2016Credit Suisse GroupLower Price TargetNeutral$33.00 ➝ $30.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
(Data available from 1/27/2016 forward)
Tenet Healthcare logo
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical, off-campus emergency, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2019, the company operated 65 hospitals, 24 surgical hospitals, and approximately 159 outpatient centers, as well as 260 ambulatory surgery, 39 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $49.76
$49.46
$50.59

50 Day Range

MA: $43.07
$34.30
$50.74

52 Week Range

Now: $49.76
$10.00
$51.05

Volume

1,051,991 shs

Average Volume

1,026,790 shs

Market Capitalization

$5.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Piper Sandler, Raymond James, Royal Bank of Canada, Smith Barney Citigroup, SunTrust Banks, Inc., Truist, UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Tenet Healthcare?

17 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $41.47, suggesting a possible downside of 16.7%. UBS Group AG has the highest price target set, predicting THC will reach $60.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $20.00 for Tenet Healthcare in the next year.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 1 sell rating, 4 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is 469-893-2200 and its investor relations email address is [email protected]th.com. The official website for Tenet Healthcare is www.tenethealth.com.